Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)
China · Delayed Price · Currency is CNY 5.09
+0.12 (2.41%)
Feb 3, 2026, 3:04 PM CST
Chongqing Lummy Pharmaceutical Company Description
Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China.
It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists.
Chongqing Lummy Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Chongqing, China.
Chongqing Lummy Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 1999 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 1,019 |
| CEO | Rongzhao Qiu |
Contact Details
Address: Building B, Huangshan Avenue Chongqing, Sichuan Province 401121 China | |
| Phone | 86 23 6730 0395 |
| Website | cqlummy.com |
Stock Details
| Ticker Symbol | 300006 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000H10 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Rongzhao Qiu | General Manager |
| Xue Feng Leng | Deputy GM and Vice Chairman |
| Wen Lai | Financial Director |
| Dan Cui | Deputy GM, Secretary and General Counsel |
| Song Lin | Deputy GM and Director |
| Ruoyue Wang | Deputy General Manager |